Risk factors | Death n = 70 | OR IC95% | p-value | |
Age (month) | 25 - 60 | 18 (19.4) |
| 1 |
≤2 | 27 (37.5) | 2.36 (1.12 - 4.94) | 0.022 | |
3 - 24 | 25 (29.1) | 1.89 (0.89 - 4.02) | 0.097 | |
Sex | Boys | 41 (26.8) |
| 1 |
Girls | 29 (29.6) | 1.1 [0.6; 2.1] | 0.63 | |
Address | Rural | 40 (28.2) |
| 1 |
Urban | 30 (27.5) | 1 [0.5; 1.8] | 0.91 | |
Vaccination statute | Vaccinated | 24 (34.3) |
| 1 |
Not vaccinated | 46 (65.7) | 2.5 [1.4; 4.4] | 0.002 | |
ATB received before | No | 29 (23.8) |
| 1 |
Yes | 41 (31.8) | 1.4 [0.9; 2.6] | 0.158 | |
Malnutrition | No | 45 (22.4) |
| 1 |
Yes | 25 (50) | 3.5 [1.8; 6.6] | 0.0002 | |
Transfer | No | 35 (21.9) |
| 1 |
Yes | 35 (38.5) | 2.3 [1.3; 3.9] | 0.005 | |
C reactive protein | ≤5 | 5 (16.7) |
| 1 |
6 - 100 | 48 (27.6) | 1.90 (0.68 - 5.26) | 0.21 | |
>100 | 17 (36.2) | 2.83 (0.91 - 8.76) | 0.07 | |
Malaria test | Positive | 17 (19.1) |
| 1 |
Negative | 53 (32.7) | 2.1[1.1; 3.9] | 0.021 | |
Aspect du CSF* | Clear | 36 (21.4) |
| 1 |
Trouble | 34 (41) | 2.5 [1.4; 4.5] | 0.001 | |
GB CSF ** | <10 | 29 (18.8) |
| 1 |
10 - 99 | 22 (40) | 2.87 (1.46 - 5.63) | 0.002 | |
≥100 | 19 (55.7) | 3.5 (1.71 - 7.38) | 0.0006 | |
Stay (days) | 4 - 10 | 6 (5.7) |
| 1 |
1 - 3 | 56 (93.3) | 231.0 (62.5 - 853.5) | <0.0001 | |
11 - 20 | 6 (9.7) | 1.76 (0.54 - 5.74) | 0.34 | |
≥21 | 2 (8.3) | 1.5 (0.28 - 7.93) | 0.63 |